-
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)McMurray JJV, DeMets DL, DAPA-HF Committees and Investigators. -
Is Cardiac Diastolic Dysfunction a Part of Post-Menopausal Syndrome?P Z Maslov, JK Kim, E Argulian et al.
-
Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failureHC Chang, CJ Huang, HM Cheng et al.
-
Heart Failure With Improved Ejection Fraction-Is it Possible to Escape One’s Past?G Gulat, JE Udelson.
-
The Management of Atrial Fibrillation in Heart Failure: An Expert Panel ConsensusD Farmakis, C Chrysohoou, G Giamouzis et al.
-
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart FailureMcMurray JJ, Krum H, ATMOSPHERE Committees Investigators.
-
Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionMcMurray JJV, SD Solomon, DAPA-HF Committees and Investigators.
-
Association of Cardiovascular Disease With Respiratory DiseaseP Carter, J Lagan, C Fortune et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
